Related Experiment Video
Updated: Aug 16, 2026

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
Published on: October 7, 2010
Transmission of cell-associated human cytomegalovirus isolates between various cell types using polymorphonuclear
Berenike Braun1, Christian Sinzger2
1Institute for Virology, Ulm University Medical Center, Ulm, Germany. berenike.braun@uni-ulm.de.
Abstract:
Polymorphonuclear leukocytes (PMNs) are regarded as vehicles for the hematogenous dissemination of human cytomegalovirus (HCMV). In cell culture, this concept has been validated with cell-free laboratory strains but not yet with clinical HCMV isolates that grow strictly cell-associated. We, therefore, aimed to evaluate whether PMNs can also transmit such isolates from initially infected fibroblasts to other cell types, which might further clarify the role of PMNs in HCMV dissemination and provide a model to search for potential inhibitors. PMNs, which have been isolated from HCMV-seronegative individuals, were added for 3 h to fibroblasts infected with recent cell-associated HCMV isolates, then removed and transferred to various recipient cell cultures. The transfer efficiency in the recipient cultures was evaluated by immunofluorescence staining of viral immediate early antigens. Soluble derivatives of the cellular HCMV entry receptor PDGFRα were analyzed for their potential to interfere with this transfer. All of five tested HCMV isolates could be transferred to fibroblasts, endothelial and epithelial cells with transfer rates ranging from 2 to 9%, and the transferred viruses could spread focally in these recipient cells within 1 week. The PDGFRα-derived peptides IK40 and GT40 reduced transfer by 40 and 70% when added during the uptake step. However, when added during the transfer step, only IK40 was effective, inhibiting transmission by 20% on endothelial cells and 50-60% on epithelial cells and fibroblasts. These findings further corroborate the assumption of cell-associated HCMV dissemination by PMNs and demonstrate that it is possible to inhibit this transmission mode.
Insights
Polymorphonuclear leukocytes (PMNs) transmit cell-associated human cytomegalovirus (HCMV) isolates between cells. Soluble PDGFRα peptides can inhibit this transmission, offering a potential therapeutic strategy against HCMV spread.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Polymorphonuclear leukocytes (PMNs) are implicated in the spread of human cytomegalovirus (HCMV).
- Previous studies validated PMN-mediated HCMV dissemination using cell-free lab strains, but not cell-associated clinical isolates.
- The role of PMNs in transmitting cell-associated HCMV remains incompletely understood.
Purpose of the Study:
- To investigate if PMNs can transmit cell-associated HCMV isolates from infected fibroblasts to other cell types.
- To establish a model for studying HCMV dissemination via PMNs.
- To explore potential inhibitors of PMN-mediated HCMV transmission.
Main Methods:
- PMNs from HCMV-seronegative donors were incubated with HCMV-infected fibroblasts.
- PMNs were transferred to various recipient cell cultures (fibroblasts, endothelial, epithelial cells).
- Transfer efficiency was assessed by viral immediate early antigen detection; PDGFRα-derived peptides were tested for inhibitory effects.
Main Results:
- All five tested cell-associated HCMV isolates were transmitted by PMNs to recipient cells with 2-9% efficiency.
- Transmitted HCMV subsequently spread focally within recipient cell cultures.
- PDGFRα peptides IK40 and GT40 significantly inhibited PMN-mediated HCMV uptake; IK40 also inhibited transfer.
Conclusions:
- PMNs facilitate the dissemination of cell-associated HCMV isolates.
- This study provides a model for evaluating PMN-mediated HCMV transmission.
- Targeting PDGFRα interactions presents a potential strategy to inhibit HCMV spread via PMNs.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015